Somatic-cell therapy medicine

« Back to Glossary Index
image_pdfSave as PDFimage_printPrint this page

A somatic-cell therapy medicine contains cells or tissues that have been manipulated to change their biological characteristics, and subsequently reintroduced into patients. These cells or tissues can be of autologous, allogeneic, or xenogeneic origin (cells obtained from a donor of a different species). The aim with somatic-cell therapy is to cure, diagnose, or prevent diseases.

Related Articles:
  • EMA Committees: Committee for Advanced Therapies (CAT)
    The EMA Committee for Advanced Therapies (CAT) reviews the quality, safety, and efficacy of Advanced-Therapy Medicinal Products (ATMPs).
  • Marketing authorisation
    Before a medicinal product can be marketed and sold, a marketing authorisation must be obtained from the relevent National Competent Authorities. The marketing authorisation application process can take one of two paths - the decentralised procedure, or the centralised procedure. In some cases in Europe, the centralised procedure is mandatory.
« Back to Glossary Index
Related Terms:

Find Out More

Toolbox

Guidance

Glossary

Creative Commons

Webinars